Symbols / ZTS Stock $116.65 -1.04% Zoetis Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NYQ
ZTS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Ms. Kristin C. Peck
Exch · Country NYQ · United States
Market Cap 49.24B
Enterprise Value 56.24B
Income 2.67B
Sales 9.47B
FCF (ttm) 1.79B
Book/sh 7.84
Cash/sh 5.48
Employees 14,500
Insider 10d —
IPO Feb 01, 2013
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 33.22%
P/E 19.38
Forward P/E 15.40
PEG 1.89
P/S 5.20
P/B 14.88
P/C —
EV/EBITDA 13.83
EV/Sales 5.94
Quick Ratio 1.75
Current Ratio 3.03
Debt/Eq 279.59
LT Debt/Eq —
EPS (ttm) 6.02
EPS next Y 7.57
EPS Growth 6.10%
Revenue Growth 3.00%
EPS Gr Q/Q 3.80%
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-02-12
ROA 15.25%
ROE 65.99%
ROIC —
Gross Margin 71.89%
Oper. Margin 34.69%
Profit Margin 28.23%
Shs Outstand 420.52M
Shs Float 421.30M
Insider Own 0.15%
Instit Own 100.85%
Short Float 3.63%
Short Ratio 3.69
Short Interest 13.50M
52W High 172.23
vs 52W High -32.27%
52W Low 113.29
vs 52W Low 2.97%
Beta 0.97
Impl. Vol. 0.78%
Rel Volume 0.73
Avg Volume 4.06M
Volume 2.97M
Target (mean) $150.29
Tgt Median $145.00
Tgt Low $127.00
Tgt High $190.00
# Analysts 17
Recom Buy
Prev Close $117.87
Price $116.65
Change -1.04%
About

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$150.29
Mean price target
2. Current target
$116.65
Latest analyst target
3. DCF / Fair value
$76.66
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$116.65
Low
$127.00
High
$190.00
Mean
$150.29

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-28 main UBS Neutral → Neutral $130
2026-04-15 init Citigroup — → Buy $145
2026-02-13 main B of A Securities Neutral → Neutral $140
2026-01-22 down Piper Sandler Overweight → Neutral $135
2025-12-09 init Barclays — → Equal-Weight $136
2025-12-03 reit BTIG Buy → Buy $160
2025-11-21 init Keybanc — → Sector Weight —
2025-11-18 main Stifel Hold → Hold $130
2025-11-12 main BTIG Buy → Buy $160
2025-11-10 main Morgan Stanley Overweight → Overweight $175
2025-11-05 main UBS Neutral → Neutral $141
2025-11-05 main JP Morgan Overweight → Overweight $200
2025-10-20 main UBS Neutral → Neutral $158
2025-09-09 reit Argus Research Buy → Buy $190
2025-08-11 main Piper Sandler Overweight → Overweight $215
2025-07-17 down Leerink Partners Outperform → Market Perform $155
2025-06-18 down Stifel Buy → Hold $160
2025-05-12 main Piper Sandler Overweight → Overweight $210
2025-05-07 main UBS Neutral → Neutral $170
2025-04-14 main Stifel Buy → Buy $165
News
RSS: Latest ZTS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-31 SARBAUGH KEITH Officer — 1,528 — —
2026-03-09 NORDEN GREGORY Director — 1,213 $0.00 $0
2026-02-19 PARENT LOUISE M Director — 1,619 — —
2026-02-19 BISARO PAUL M. Director — 1,619 — —
2026-02-19 REED WILLIE M Director — 1,619 — —
2026-02-19 MCCALLISTER MICHAEL B Director — 1,619 — —
2026-02-19 D AMELIO FRANK A Director — 1,619 $127.28 $206,109
2026-02-19 KHOSLA SANJAY Director — 1,619 $127.28 $206,109
2026-02-19 NORDEN GREGORY Director — 1,619 — —
2026-02-19 PECK KRISTIN C Chief Executive Officer — 7,354 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
9,467.00
+2.28%
9,256.00
+8.33%
8,544.00
+5.74%
8,080.00
Operating Revenue
9,467.00
+2.28%
9,256.00
+8.33%
8,544.00
+5.74%
8,080.00
Cost Of Revenue
2,666.00
-1.95%
2,719.00
+6.17%
2,561.00
+4.36%
2,454.00
Reconciled Cost Of Revenue
2,307.00
-2.37%
2,363.00
+6.49%
2,219.00
+3.74%
2,139.00
Gross Profit
6,801.00
+4.04%
6,537.00
+9.26%
5,983.00
+6.35%
5,626.00
Operating Expense
3,204.00
+1.88%
3,145.00
+7.93%
2,914.00
+8.01%
2,698.00
Research And Development
698.00
+1.75%
686.00
+11.73%
614.00
+13.91%
539.00
Selling General And Administration
2,378.00
+2.59%
2,318.00
+7.76%
2,151.00
+7.07%
2,009.00
Total Expenses
5,870.00
+0.10%
5,864.00
+7.11%
5,475.00
+6.27%
5,152.00
Operating Income
3,597.00
+6.04%
3,392.00
+10.52%
3,069.00
+4.82%
2,928.00
EBITDA
4,069.00
+5.55%
3,855.00
+5.16%
3,666.00
+9.69%
3,342.00
Normalized EBITDA
4,173.00
+4.43%
3,996.00
+8.00%
3,700.00
+6.91%
3,461.00
Reconciled Depreciation
487.00
-2.01%
497.00
+1.22%
491.00
+5.59%
465.00
EBIT
3,582.00
+6.67%
3,358.00
+5.76%
3,175.00
+10.36%
2,877.00
Total Unusual Items
-104.00
+26.24%
-141.00
-314.71%
-34.00
+71.43%
-119.00
Total Unusual Items Excluding Goodwill
-104.00
+26.24%
-141.00
-314.71%
-34.00
+71.43%
-119.00
Special Income Charges
-59.00
+35.16%
-91.00
-800.00%
13.00
+122.81%
-57.00
Impairment Of Capital Assets
5.00
-66.67%
15.00
-57.14%
35.00
-10.26%
39.00
Restructuring And Mergern Acquisition
29.00
-21.62%
37.00
-28.85%
52.00
+477.78%
9.00
Write Off
22.00
0.00
-100.00%
1.00
-88.89%
9.00
Net Income
2,673.00
+7.52%
2,486.00
+6.06%
2,344.00
+10.88%
2,114.00
Pretax Income
3,360.00
+7.25%
3,133.00
+6.71%
2,936.00
+10.54%
2,656.00
Net Non Operating Interest Income Expense
-129.00
-8.40%
-119.00
+11.19%
-134.00
+21.64%
-171.00
Interest Expense Non Operating
222.00
-1.33%
225.00
-5.86%
239.00
+8.14%
221.00
Net Interest Income
-129.00
-8.40%
-119.00
+11.19%
-134.00
+21.64%
-171.00
Interest Expense
222.00
-1.33%
225.00
-5.86%
239.00
+8.14%
221.00
Interest Income Non Operating
93.00
-12.26%
106.00
+0.95%
105.00
+110.00%
50.00
Interest Income
93.00
-12.26%
106.00
+0.95%
105.00
+110.00%
50.00
Other Income Expense
-108.00
+22.86%
-140.00
-14100.00%
1.00
+100.99%
-101.00
Other Non Operating Income Expenses
-4.00
-500.00%
1.00
-97.14%
35.00
+94.44%
18.00
Gain On Sale Of Security
-45.00
+10.00%
-50.00
-6.38%
-47.00
+24.19%
-62.00
Gain On Sale Of Business
-3.00
+86.96%
-23.00
-122.77%
101.00
0.00
Tax Provision
687.00
+7.85%
637.00
+6.88%
596.00
+9.36%
545.00
Tax Rate For Calcs
0.00
+0.49%
0.00
+0.00%
0.00
-1.07%
0.00
Tax Effect Of Unusual Items
-21.22
+25.88%
-28.62
-314.71%
-6.90
+71.73%
-24.42
Net Income Including Noncontrolling Interests
2,673.00
+7.09%
2,496.00
+6.67%
2,340.00
+10.85%
2,111.00
Net Income From Continuing Operation Net Minority Interest
2,673.00
+7.52%
2,486.00
+6.06%
2,344.00
+10.88%
2,114.00
Net Income From Continuing And Discontinued Operation
2,673.00
+7.52%
2,486.00
+6.06%
2,344.00
+10.88%
2,114.00
Net Income Continuous Operations
2,673.00
+7.09%
2,496.00
+6.67%
2,340.00
+10.85%
2,111.00
Minority Interests
0.00
+100.00%
-10.00
-350.00%
4.00
+33.33%
3.00
Normalized Income
2,755.78
+6.06%
2,598.38
+9.59%
2,371.10
+7.36%
2,208.58
Net Income Common Stockholders
2,673.00
+7.52%
2,486.00
+6.06%
2,344.00
+10.88%
2,114.00
Diluted EPS
6.02
+10.05%
5.47
+7.89%
5.07
+12.92%
4.49
Basic EPS
6.03
+10.24%
5.47
+7.68%
5.08
+12.64%
4.51
Basic Average Shares
443.40
-2.38%
454.20
-1.52%
461.20
-1.64%
468.90
Diluted Average Shares
443.80
-2.42%
454.80
-1.62%
462.30
-1.72%
470.40
Diluted NI Availto Com Stockholders
2,673.00
+7.52%
2,486.00
+6.06%
2,344.00
+10.88%
2,114.00
Amortization
128.00
-9.22%
141.00
-5.37%
149.00
-0.67%
150.00
Amortization Of Intangibles Income Statement
128.00
-9.22%
141.00
-5.37%
149.00
-0.67%
150.00
Depreciation Amortization Depletion Income Statement
128.00
-9.22%
141.00
-5.37%
149.00
-0.67%
150.00
Depreciation And Amortization In Income Statement
128.00
-9.22%
141.00
-5.37%
149.00
-0.67%
150.00
Gain On Sale Of PPE
0.00
+100.00%
-16.00
0.00
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
15,467.00
+8.64%
14,237.00
-0.34%
14,286.00
-4.28%
14,925.00
Current Assets
6,768.00
+13.06%
5,986.00
-5.63%
6,343.00
-15.49%
7,506.00
Cash Cash Equivalents And Short Term Investments
2,310.00
+16.37%
1,985.00
-2.65%
2,039.00
-43.00%
3,577.00
Cash And Cash Equivalents
2,310.00
+16.37%
1,985.00
-2.65%
2,039.00
-43.00%
3,577.00
Receivables
1,590.00
+20.82%
1,316.00
+0.92%
1,304.00
+7.33%
1,215.00
Accounts Receivable
1,590.00
+20.82%
1,316.00
+0.92%
1,304.00
+7.33%
1,215.00
Gross Accounts Receivable
1,606.00
+20.39%
1,334.00
+0.91%
1,322.00
+7.13%
1,234.00
Allowance For Doubtful Accounts Receivable
-16.00
+11.11%
-18.00
+0.00%
-18.00
+5.26%
-19.00
Inventory
2,430.00
+5.38%
2,306.00
-10.06%
2,564.00
+9.34%
2,345.00
Raw Materials
362.00
-3.98%
377.00
-16.41%
451.00
+4.88%
430.00
Work In Process
962.00
+3.11%
933.00
-3.42%
966.00
+17.09%
825.00
Finished Goods
1,106.00
+11.04%
996.00
-13.16%
1,147.00
+5.23%
1,090.00
Restricted Cash
2.00
+0.00%
2.00
+0.00%
2.00
-50.00%
4.00
Other Current Assets
436.00
+15.65%
377.00
-13.13%
434.00
+18.90%
365.00
Total Non Current Assets
8,699.00
+5.43%
8,251.00
+3.88%
7,943.00
+7.06%
7,419.00
Net PPE
3,969.00
+9.94%
3,610.00
+5.13%
3,434.00
+15.51%
2,973.00
Gross PPE
6,894.00
+10.39%
6,245.00
+3.60%
6,028.00
+14.38%
5,270.00
Accumulated Depreciation
-2,925.00
-11.01%
-2,635.00
-1.58%
-2,594.00
-12.93%
-2,297.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
33.00
+17.86%
28.00
+12.00%
25.00
-3.85%
26.00
Buildings And Improvements
1,549.00
+19.89%
1,292.00
-1.82%
1,316.00
+9.94%
1,197.00
Machinery Furniture Equipment
3,729.00
+11.21%
3,353.00
-0.56%
3,372.00
+11.92%
3,013.00
Construction In Progress
1,295.00
-4.29%
1,353.00
+24.70%
1,085.00
+33.29%
814.00
Other Properties
288.00
+31.51%
219.00
-4.78%
230.00
+4.55%
220.00
Goodwill And Other Intangible Assets
3,765.00
-2.23%
3,851.00
-6.00%
4,097.00
-0.70%
4,126.00
Goodwill
2,767.00
+1.58%
2,724.00
-1.27%
2,759.00
+0.47%
2,746.00
Other Intangible Assets
998.00
-11.45%
1,127.00
-15.77%
1,338.00
-3.04%
1,380.00
Non Current Deferred Assets
637.00
+17.96%
540.00
+162.14%
206.00
+19.08%
173.00
Non Current Deferred Taxes Assets
637.00
+17.96%
540.00
+162.14%
206.00
+19.08%
173.00
Other Non Current Assets
328.00
+31.20%
250.00
+21.36%
206.00
+40.14%
147.00
Total Liabilities Net Minority Interest
12,136.00
+28.19%
9,467.00
+1.85%
9,295.00
-11.66%
10,522.00
Current Liabilities
2,235.00
-34.50%
3,412.00
+80.62%
1,889.00
-40.35%
3,167.00
Payables And Accrued Expenses
1,718.00
+14.84%
1,496.00
+6.70%
1,402.00
-1.13%
1,418.00
Payables
866.00
+15.47%
750.00
+4.31%
719.00
-2.31%
736.00
Accounts Payable
487.00
+12.47%
433.00
+5.35%
411.00
+1.48%
405.00
Dividends Payable
232.00
+3.57%
224.00
+13.13%
198.00
+13.79%
174.00
Current Accrued Expenses
852.00
+14.21%
746.00
+9.22%
683.00
+0.15%
682.00
Pensionand Other Post Retirement Benefit Plans Current
410.00
-7.03%
441.00
+15.45%
382.00
+27.33%
300.00
Total Tax Payable
147.00
+58.06%
93.00
-15.45%
110.00
-29.94%
157.00
Income Tax Payable
147.00
+58.06%
93.00
-15.45%
110.00
-29.94%
157.00
Current Debt And Capital Lease Obligation
—
1,350.00
+44900.00%
3.00
-99.78%
1,352.00
Current Debt
—
1,350.00
+44900.00%
3.00
-99.78%
1,352.00
Other Current Borrowings
—
1,350.00
—
1,350.00
Other Current Liabilities
107.00
-14.40%
125.00
+22.55%
102.00
+5.15%
97.00
Total Non Current Liabilities Net Minority Interest
9,901.00
+63.52%
6,055.00
-18.24%
7,406.00
+0.69%
7,355.00
Long Term Debt And Capital Lease Obligation
9,238.00
+71.26%
5,394.00
-20.11%
6,752.00
+0.21%
6,738.00
Long Term Debt
9,042.00
+73.22%
5,220.00
-20.48%
6,564.00
+0.18%
6,552.00
Long Term Capital Lease Obligation
196.00
+12.64%
174.00
-7.45%
188.00
+1.08%
186.00
Tradeand Other Payables Non Current
276.00
+1.47%
272.00
+0.37%
271.00
+5.04%
258.00
Non Current Deferred Liabilities
139.00
-16.77%
167.00
+14.38%
146.00
+2.82%
142.00
Non Current Deferred Taxes Liabilities
139.00
-16.77%
167.00
+14.38%
146.00
+2.82%
142.00
Other Non Current Liabilities
248.00
+11.71%
222.00
-6.33%
237.00
+9.22%
217.00
Stockholders Equity
3,331.00
-30.17%
4,770.00
-4.54%
4,997.00
+13.44%
4,405.00
Common Stock Equity
3,331.00
-30.17%
4,770.00
-4.54%
4,997.00
+13.44%
4,405.00
Capital Stock
5.00
+0.00%
5.00
+0.00%
5.00
+0.00%
5.00
Common Stock
5.00
+0.00%
5.00
+0.00%
5.00
+0.00%
5.00
Share Issued
501.89
+0.00%
501.89
+0.00%
501.89
+0.00%
501.89
Ordinary Shares Number
424.93
-5.25%
448.47
-2.16%
458.37
-1.17%
463.81
Treasury Shares Number
76.96
+44.08%
53.42
+22.73%
43.52
+14.29%
38.08
Additional Paid In Capital
1,101.00
-6.85%
1,182.00
+4.32%
1,133.00
+4.14%
1,088.00
Retained Earnings
13,744.00
+14.84%
11,968.00
+16.25%
10,295.00
+18.77%
8,668.00
Gains Losses Not Affecting Retained Earnings
-834.00
+11.28%
-940.00
-12.04%
-839.00
-2.69%
-817.00
Treasury Stock
10,685.00
+43.52%
7,445.00
+33.02%
5,597.00
+23.31%
4,539.00
Minority Interest
0.00
0.00
+100.00%
-6.00
-200.00%
-2.00
Other Equity Adjustments
-834.00
+11.28%
-940.00
-12.04%
-839.00
-2.69%
-817.00
Total Equity Gross Minority Interest
3,331.00
-30.17%
4,770.00
-4.43%
4,991.00
+13.35%
4,403.00
Total Capitalization
12,373.00
+23.85%
9,990.00
-13.59%
11,561.00
+5.51%
10,957.00
Working Capital
4,533.00
+76.11%
2,574.00
-42.21%
4,454.00
+2.65%
4,339.00
Invested Capital
12,373.00
+9.11%
11,340.00
-1.94%
11,564.00
-6.05%
12,309.00
Total Debt
9,238.00
+36.98%
6,744.00
-0.16%
6,755.00
-16.50%
8,090.00
Net Debt
6,732.00
+46.83%
4,585.00
+1.26%
4,528.00
+4.65%
4,327.00
Capital Lease Obligations
196.00
+12.64%
174.00
-7.45%
188.00
+1.08%
186.00
Net Tangible Assets
-434.00
-147.23%
919.00
+2.11%
900.00
+222.58%
279.00
Tangible Book Value
-434.00
-147.23%
919.00
+2.11%
900.00
+222.58%
279.00
Line Of Credit
—
0.00
-100.00%
3.00
+50.00%
2.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
2,904.00
-1.66%
2,953.00
+25.50%
2,353.00
+23.06%
1,912.00
Cash Flow From Continuing Operating Activities
2,904.00
-1.66%
2,953.00
+25.50%
2,353.00
+23.06%
1,912.00
Net Income From Continuing Operations
2,673.00
+7.09%
2,496.00
+6.67%
2,340.00
+10.85%
2,111.00
Depreciation Amortization Depletion
487.00
-2.01%
497.00
+1.22%
491.00
+5.59%
465.00
Depreciation
330.00
—
—
—
Amortization Cash Flow
157.00
—
—
—
Depreciation And Amortization
487.00
-2.01%
497.00
+1.22%
491.00
+5.59%
465.00
Amortization Of Intangibles
157.00
—
—
—
Other Non Cash Items
-8.00
-33.33%
-6.00
+25.00%
-8.00
-161.54%
13.00
Pension And Employee Benefit Expense
—
0.00
0.00
-100.00%
3.00
Stock Based Compensation
83.00
+12.16%
74.00
+23.33%
60.00
-3.23%
62.00
Provisionand Write Offof Assets
68.00
-29.90%
97.00
-15.65%
115.00
+51.32%
76.00
Asset Impairment Charge
47.00
+51.61%
31.00
-32.61%
46.00
-13.21%
53.00
Deferred Tax
-52.00
+84.62%
-338.00
-454.10%
-61.00
+78.67%
-286.00
Deferred Income Tax
-52.00
+84.62%
-338.00
-454.10%
-61.00
+78.67%
-286.00
Operating Gains Losses
14.00
-39.13%
23.00
+119.49%
-118.00
-200.85%
117.00
Gain Loss On Investment Securities
11.00
—
—
114.00
Change In Working Capital
-408.00
-616.46%
79.00
+115.43%
-512.00
+26.75%
-699.00
Change In Receivables
-236.00
-286.89%
-61.00
+40.20%
-102.00
+25.55%
-137.00
Changes In Account Receivables
-236.00
-286.89%
-61.00
+40.20%
-102.00
+25.55%
-137.00
Change In Inventory
-199.00
-397.50%
-40.00
+88.92%
-361.00
+25.72%
-486.00
Change In Payables And Accrued Expense
46.00
+48.39%
31.00
+138.46%
13.00
+144.83%
-29.00
Change In Payable
46.00
+48.39%
31.00
+138.46%
13.00
+144.83%
-29.00
Change In Account Payable
46.00
+48.39%
31.00
+138.46%
13.00
+144.83%
-29.00
Change In Other Working Capital
61.00
+458.82%
-17.00
+50.00%
-34.00
-134.69%
98.00
Change In Other Current Assets
-165.00
-417.31%
52.00
+154.74%
-95.00
-371.43%
35.00
Change In Other Current Liabilities
85.00
-25.44%
114.00
+70.15%
67.00
+137.22%
-180.00
Investing Cash Flow
-748.00
-137.46%
-315.00
+59.46%
-777.00
+12.00%
-883.00
Cash Flow From Continuing Investing Activities
-748.00
-137.46%
-315.00
+59.46%
-777.00
+12.00%
-883.00
Capital Expenditure
-621.00
+5.19%
-655.00
+10.52%
-732.00
-24.91%
-586.00
Capital Expenditure Reported
-621.00
+5.19%
-655.00
+10.52%
-732.00
-24.91%
-586.00
Net Investment Purchase And Sale
-100.00
-275.44%
57.00
+612.50%
8.00
-42.86%
14.00
Purchase Of Investment
-100.00
-1900.00%
-5.00
-25.00%
-4.00
+55.56%
-9.00
Sale Of Investment
—
62.00
+416.67%
12.00
-47.83%
23.00
Net Business Purchase And Sale
-28.00
-109.82%
285.00
+583.05%
-59.00
+81.09%
-312.00
Purchase Of Business
-28.00
-250.00%
-8.00
+94.84%
-155.00
+50.32%
-312.00
Gain Loss On Sale Of Business
3.00
-86.96%
23.00
+119.49%
-118.00
0.00
Net Other Investing Changes
1.00
+150.00%
-2.00
-133.33%
6.00
+500.00%
1.00
Financing Cash Flow
-1,870.00
+29.70%
-2,660.00
+14.44%
-3,109.00
-243.92%
-904.00
Cash Flow From Continuing Financing Activities
-1,870.00
+29.70%
-2,660.00
+14.44%
-3,109.00
-243.92%
-904.00
Net Issuance Payments Of Debt
2,498.00
+83366.67%
-3.00
+99.78%
-1,349.00
-199.93%
1,350.00
Issuance Of Debt
3,848.00
0.00
0.00
-100.00%
1,348.00
Repayment Of Debt
-1,350.00
0.00
+100.00%
-1,350.00
0.00
Long Term Debt Issuance
3,848.00
0.00
0.00
-100.00%
1,348.00
Long Term Debt Payments
-1,350.00
0.00
+100.00%
-1,350.00
0.00
Net Long Term Debt Issuance
2,498.00
0.00
+100.00%
-1,350.00
-200.15%
1,348.00
Net Short Term Debt Issuance
0.00
+100.00%
-3.00
-400.00%
1.00
-50.00%
2.00
Net Common Stock Issuance
-3,235.00
-74.11%
-1,858.00
-70.15%
-1,092.00
+31.49%
-1,594.00
Common Stock Payments
-3,235.00
-74.11%
-1,858.00
-70.15%
-1,092.00
+31.49%
-1,594.00
Common Stock Dividend Paid
-889.00
-13.10%
-786.00
-13.58%
-692.00
-13.26%
-611.00
Cash Dividends Paid
-889.00
-13.10%
-786.00
-13.58%
-692.00
-13.26%
-611.00
Repurchase Of Capital Stock
-3,235.00
-74.11%
-1,858.00
-70.15%
-1,092.00
+31.49%
-1,594.00
Proceeds From Stock Option Exercised
-11.00
-37.50%
-8.00
-129.63%
27.00
+171.05%
-38.00
Net Other Financing Charges
-233.00
-4560.00%
-5.00
-66.67%
-3.00
+72.73%
-11.00
Changes In Cash
286.00
+1400.00%
-22.00
+98.56%
-1,533.00
-1326.40%
125.00
Effect Of Exchange Rate Changes
39.00
+221.88%
-32.00
-357.14%
-7.00
+75.86%
-29.00
Beginning Cash Position
1,987.00
-2.65%
2,041.00
-43.00%
3,581.00
+2.75%
3,485.00
End Cash Position
2,312.00
+16.36%
1,987.00
-2.65%
2,041.00
-43.00%
3,581.00
Free Cash Flow
2,283.00
-0.65%
2,298.00
+41.76%
1,621.00
+22.25%
1,326.00
Interest Paid Supplemental Data
261.00
-4.74%
274.00
-7.12%
295.00
+21.90%
242.00
Income Tax Paid Supplemental Data
715.00
-19.84%
892.00
+18.30%
754.00
+18.18%
638.00
Sale Of Business
—
293.00
+205.21%
96.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category